Skip to main content
Waqoo Inc. logo

Waqoo Inc. — Investor Relations & Filings

Ticker · 4937 ISIN · JP3992050009 T Manufacturing
Open in API
Filings indexed 50 across all filing types
Latest filing 2026-05-14 Investor Presentation
Country JP Japan
Listing T 4937

About Waqoo Inc.

https://en.waqoo.jp/

Waqoo Inc. is a company that operates a Direct-to-Consumer (D2C) business focused on the beauty and health sectors. The company plans, develops, and sells its own branded products, including cosmetics, skincare, and health supplements. It utilizes information technology and digital marketing to sell directly to consumers through its e-commerce websites and other online platforms. In addition to its D2C business, the company is also engaged in the medical support field, with a focus on regenerative medicine.

Recent filings

Filing Released Lang Actions
2026年９月期 第２四半期 決算補足説明資料
Investor Presentation Classification · 95% confidence The document is titled 決算補足説明資料 (supplemental explanatory materials for the financial results), presented as a slide deck with an agenda, executive summary, KPI trends, segment analysis, balance sheet, cash flows, and forward-looking guidance. It is a detailed presentation distributed to investors and analysts alongside the Q2 results, rather than the official interim regulatory filing itself. This matches the definition of an Investor Presentation (Code: IP).
2026-05-14 Japanese
確認書
Regulatory Filings Classification · 98% confidence The document is a confirmation letter (“確認書”) under the Financial Instruments and Exchange Act (FIEA) where the CEO attests to the accuracy of the company’s semi‐annual report. It contains no financial statements itself and serves as an officer certification rather than the actual interim report. Per the “Certification Rule,” this should be classified as a Regulatory Filing (RNS), not as an Interim/Quarterly Report.
2026-05-14 Japanese
半期報告書－第21期(2025/10/01－2026/09/30)
Interim / Quarterly Report Classification · 88% confidence The document is a Japanese "半期報告書" (half-year report) containing detailed interim consolidated financial statements (中間連結財務諸表), management discussion & analysis, segment data and corporate information for the period October 1, 2025 to March 31, 2026. It is not merely an announcement but the full interim report itself, matching the definition of an Interim / Quarterly Report. H1 2026
2026-05-14 Japanese
確認書
Regulatory Filings Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-2 of the Financial Instruments and Exchange Act in Japan. This is a mandatory regulatory filing that accompanies an Annual Securities Report (Yukashoken Hokokusho) to confirm the accuracy of the report's contents. Since it is a specific regulatory filing required by law and does not fit into the other categories like 10-K or IR, it is classified as a Regulatory Filing (RNS).
2025-12-23 Japanese
有価証券報告書－第20期(2024/10/01－2025/09/30)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the standard annual financial report filed by public companies in Japan under the Financial Instruments and Exchange Act. It contains comprehensive financial data, including consolidated and non-consolidated financial indicators, balance sheets, and management analysis for the fiscal year ending September 30, 2025. This matches the definition of an Annual Report (10-K equivalent). FY 2025
2025-12-23 Japanese
意見表明報告書
M&A Activity Classification · 100% confidence The document is a 'Statement of Opinion' (意見表明報告書) filed by Waqoo Inc. in response to a tender offer (公開買付け) initiated by SBC Medical Group. This document is a formal regulatory filing required under the Financial Instruments and Exchange Act of Japan (金融商品取引法) when a company expresses its position on a takeover bid. It details the board's recommendation, the rationale for the tender offer, and the background of the transaction. This fits the definition of a regulatory filing regarding M&A activity and corporate control, which is best classified under the 'TAR' (M&A Activity) category as it specifically pertains to a takeover bid and the target company's response.
2025-11-14 Japanese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.